Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Compass Therapeutics, Inc. (CMPX) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-14.26M |
|
-- |
|
-- |
|
$15.82M |
|
$-15.82M |
|
$1.56M |
|
$-14.26M |
|
$-14.26M |
|
$-14.26M |
|
$-14.26M |
|
$-14.26M |
|
$-14.26M |
|
$-15.82M |
|
$-15.82M |
|
168.78M |
|
168.78M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$221.12M |
|
$0.12M |
|
$10.14M |
|
$231.26M |
|
$12.41M |
|
-- |
|
$9.23M |
|
$21.65M |
|
$209.61M |
|
$209.61M |
|
$209.61M |
|
177.57M |
|
| Cash Flow Statement Financials | |
$-35.89M |
|
$-89.93M |
|
$128.55M |
|
$44.05M |
|
$46.78M |
|
$2.73M |
|
$6.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.82 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.80% |
|
-6.80% |
|
-6.17% |
|
-6.80% |
|
$1.18 |
|
$-0.21 |
|
$-0.21 |
|